Skip to main content
TipRanks
Go Ultimate75% OFF

Center Laboratories, Inc. Insider Profile

4 Followers

Center Laboratories, Inc., Ten Percent Owner at Windtree Therapeutics, holds 2.48M shares in Windtree Therapeutics (Ticker: WINT). Most recently, Center Laboratories, Inc. Bought 1,294,260 shares of Windtree Therapeutics on Jan 10, 2022 for an estimated value of $2.38M.

Center Laboratories, Inc.'s Trading History

WINT
Windtree Therapeutics
Jan 10, 2022Ten Percent OwnerInformative Buy2.38M$29.74K
WINT
Insider Shares: 2.48M (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 10, 2022Uninformative Sell$0.003,551,750$0.00―
Jan 10, 2022Informative Buy$2.38M1,294,260$1.84―

You May Also Like

Center Laboratories, Inc. insider profile FAQ

What stocks does Center Laboratories, Inc. hold?
Center Laboratories, Inc. holds: WINT stocks.
What was Center Laboratories, Inc.’s latest transaction?
Center Laboratories, Inc.’s latest transaction was an Informative Buy of $2.38M.
What is Center Laboratories, Inc.'s role in Windtree Therapeutics?
Center Laboratories, Inc.'s role in Windtree Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.